Phase 2 Prostate Cancer (CRPC) Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Colorectal, CancerOvarian CancerCervical Cancer+7 more
Radiopharm Theranostics, Ltd61 enrolled4 locationsNCT07189871
Recruiting
Phase 2
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617
Prostate CancerProstate Cancer MetastaticMetastatic Castration-resistant Prostate Cancer+2 more
Ebrahim S Delpassand30 enrolled1 locationNCT06972628
Recruiting
Phase 2
Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer (CRPC)
Pengyuan Liu60 enrolled1 locationNCT06249750
Terminated
Phase 2
Dose finding study for CRLX301 in solid tumors
Taxane-naive castration resistant prostate cancer (CRPC)Solid Tumours
BlueLink Pharmaceuticals a subsidiary of NewLink Genetics118 enrolled4 locationsACTRN12614001292662